Cite
HARVARD Citation
Huang, C. et al. (2020). Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study. Journal for immunotherapy of cancer. 8 (2), p. . [Online].